ArticleJMIR medical informatics2025
Named Entity Recognition for Chinese Cancer Electronic Health Records-Development and Evaluation of a Domain-Specific BERT Model: Quantitative Study.
Article in JMIR medical informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The unstructured data of Chinese cancer electronic health records (EHRs) contains valuable medical expertise. Accurate medical entity recognition is crucial for building a medical-assisted decision system. Named entity recognition (NER) in cancer EHRs typically uses general models designed for English medical records. There is a lack of specialized handling for cancer-specific records and limited application to Chinese medical records. Objective: This study aims to propose a specific NER model to enhance the recognition of medical entities in Chinese cancer EHRs. Methods: Desensitized inpatient EHRs related to breast cancer were collected from a leading hospital in Beijing. Building upon the MC Bidirectional Encoder Representations from Transformers (BERT) foundation, the study further incorporated a Chinese cancer corpus for pretraining, resulting in the construction of the ChCancerBERT pretrained model. In conjunction with dilated-gated convolutional neural networks, bidirectional long short-term memory, multihead attention mechanism, and a conditional random field, this model forms a multimodel, multilevel integrated NER approach. Results: This approach effectively extracts medical entity features related to symptoms, signs, tests, treatments, and time in Chinese breast cancer EHRs. The entity recognition performance of the proposed model surpasses that of the baseline model and other models compared in the experiment. The F1-score reached 86.93%, precision reached 87.24%, and recall reached 86.61%. The model introduced in this study demonstrates exceptional performance on the CCKS2019 dataset, attaining a precision rate of 87.26%, a recall rate of 87.27%, and an impressive F1-score of 87.26%, surpassing that of existing models. Conclusions: The experiments demonstrate that the approach proposed in this study exhibits excellent performance in NER within breast cancer EHRs. This advancement will further contribute to clinical decision support for cancer treatment and research. In addition, the study reveals that incorporating domain-specific corpora in clinical NER tasks can further enhance the performance of BERT models in specialized domains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.